Persistent Signaling by Dysregulated Thrombin Receptor Trafficking Promotes Breast Carcinoma Cell Invasion

Molecular and Cellular Biology

Volumn 24, Issue 5, 2004, Pages 1990-1999

  Booden, Michelle A ^a   Eckert, Lynn B ^a   Der, Channing J ^a,b   Trejo, JoAnn ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITIDE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROLYSIS; INTERNALIZATION; LYSOSOME; METASTASIS; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; NEOPLASM METASTASIS; PROTEIN TRANSPORT; RECEPTOR, PAR-1; SIGNAL TRANSDUCTION; THROMBIN;

EID: 1342325343     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.5.1990-1999.2004     Document Type: Article

References (39)

1. Albini, A., Y. Iwamoto, H. K. Kleinman, G. R. Martin, S. A. Aaronson, J. M. Kozlowski, and R. N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
2. Bar-Sagi, D., and J. R. Feramisco. 1986. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233:1061-1068.
3. Bissell, M. J., and D. Radisky. 2001. Putting tumours in context. Nat. Rev. Cancer 1:46-54.
4. Christoforidis, S., H. M. McBride, R. D. Burgoyne, and M. Zerial. 1999. The Rab5 effector EEA1 is a core component of endosome docking. Nature 397:621-625.
5. Clark, G. J., and C. J. Der. 1995. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 35:133-144.
6. Coughlin, S. R. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258-264.
7. Dvorak, H. F., J. A. Nagy, B. Berse, L. F. Brown, K. T. Yeo, T. K. Yeo, A. M. Dvorak, L. van de Water, T. M. Sioussat, and D. R. Senger. 1992. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N. Y. Acad. Sci. 667:101-111.
8. Elenbaas, B., L. Spirio, F. Koerner, M. D. Fleming, D. B. Zimonjic, J. L. Donaher, N. C. Popescu, W. C. Hahn, and R. A. Weinberg. 2001. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15:50-65.
9. Esumi, N., D. Fan, and I. J. Fidler. 1991. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res. 51:4549-4556.
10. Even-Ram, S., B. Uziely, P. Cohen, S. Grisaru-Granovsky, M. Maoz, Y. Ginzburg, R. Reich, I. Vlodavsky, and R. Bar-Shavit. 1998, Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4:909-914.
11. Even-Ram, S. C., M. Maoz, E. Pokroy, R. Reich, B. Z. Katz, P. Gutwein, P. Altevogt, and R. Bar-Shavit. 2001. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha beta 5 integrin. J. Biol. Chem. 276:10952-10962.
12. Gilhooly, E. M., and D. P. Rose. 1999. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int. J. Oncol. 15:267-270.
13. Henrikson, K. P., S. L. Salazar, J. W. Fenton, and B. T. Pentecost. 1999. Role of thrombin receptor in breast cancer invasiveness. Br. J. Cancer 79:401-406.
14. Hung, D. T., T. K. Vu, V. I. Wheaton, K. Ishii, and S. R. Coughlin. 1992. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J. Clin. Investig. 89:1350-1353.
15. Ishii, K., J. Chen, M. Ishii, W. J. Koch, N. J. Freedman, R. J. Lefkowitz, and S. R. Coughlin. 1994. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J. Biol. Chem. 269:1125-1130.
16. Kahan, C., K. Seuwen, S. Meloche, and J. Pouyssegur. 1992. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J. Biol. Chem. 267:13369-13375.
17. Kahn, M. L., M. Nakanishi-Matsui, M. J. Shapiro, H. Ishihara, and S. R. Coughlin. 1999. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Investig. 103:879-887.
18. Marinissen, M. J., and J. S. Gutkind. 2001. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22:368-376.
19. Martin, C. B., G. M. Mahon, M. B. Klinger, R. J. Kay, M. Symons, C. J. Der, and I. P. Whitehead. 2001. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 20:1953-1963.
20. Mueller, B. M., R. A. Reisfeld, T. S. Edgington, and W. Ruf. 1992. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc. Natl. Acad. Sci. USA 89:11832-11836.
21. Mueller, B. M., and W. Ruf. 1998. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J. Clin. Investig. 101:1372-1378.
22. Nierodzik, M. L., K. Chen, K. Takeshita, J. J. Li, Y. Q. Huang, X. S. Feng, M. R. D'Andrea, P. Andrade-Gordon, and S. Karpatkin. 1998. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92:3694-3700.
23. Nierodzik, M. L., F. Kajumo, and S. Karpatkin. 1992. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res. 52:3267-3272.
24. Nierodzik, M. L., A. Plotkin, F. Kajumo, and S. Karpatkin. 1991. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J. Clin. Investig. 87:229-236.
25. Paing, M. M., A. B. Stutts, T. A. Kohout, R. J. Lefkowitz, and J. Trejo. 2002. Beta-arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J. Biol. Chem. 277:1292-1300.
26. Palumbo, J. S., and J. L. Degen. 2000. Hemostatic factors in tumor biology. J. Pediatr. Hematol. Oncol. 22:281-287.
27. Palumbo, J. S., K. W. Kombrinck, A. F. Drew, T. S. Grimes, J. H. Kiser, J. L. Degen, and T. H. Bugge. 2000. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96:3302-3309.
28. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
29. Sambrano, G. R., and S. R. Coughlin. 1999. The carboxyl tail of protease-activated receptor-1 is required for chemotaxis. Correlation of signal termination and directional migration. J. Biol. Chem. 274:20178-20184.
30. Shapiro, M. J., J. Trejo, D. Zeng, and S. R. Coughlin. 1996. Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J. Biol. Chem. 271:32874-32880.
31. Sorkin, A., and M. Von Zastrow. 2002. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3:600-614.
32. Swanson, J. A., and C. Watts. 1995. Macropinocytosis. Trends Cell Biol. 5:424-428.
33. Trejo, J., Y. Altschuler, H. W. Fu, K. E. Mostov, and S. R. Coughlin. 2000. Protease-activated receptor-1 down-regulation: a mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clathrin-coated pits. J. Biol. Chem. 275:31255-31265.
34. Trejo, J., A. J. Connolly, and S. R. Coughlin. 1996. The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice. J. Biol. Chem. 271:21536-21541.
35. Trejo, J., and S. R. Coughlin. 1999. The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. J. Biol. Chem. 274:2216-2224.
36. Trejo, J., S. R. Hammes, and S. R. Coughlin. 1998. Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc. Natl. Acad. Sci. USA 95:13698-13702.
37. Walz, D. A., and J. W. Fenton. 1994. The role of thrombin in tumor cell metastasis. Invasion Metastasis 14:303-308.
38. Wang, Y., Y. Zhou, K. Szabo, C. R. Haft, and J. Trejo. 2002. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Mol. Biol. Cell 13:1965-1976.
39. Whitehead, I. P., I. E. Zohn, and C. J. Der. 2001. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 20:1547-1555.